OrthoSpace

OrthoSpace is a sports medicine company acquired by Stryker, Inc. The company’s product, InSpace, is an orthopedic biodegradable balloon system that is a simple, safe and minimally invasive method that addresses unmet clinical needs in rotator cuff repair. InSpace is CE-Marked and received FDA clearance in July 2021.

InSpace is the first biodegradable subacromial balloon spacer, filling the gap in the shoulder continuum of care.

InnovaHealth Partners’ predecessor firm invested in OrthoSpace in 2015. Mortimer Berkowitz III was Chairman and Ariella Golomb, M.D. served as a Director of OrthoSpace before it was sold to Stryker, Inc. in March 2019.